Ingevity (NYSE: NGVT) reported Q4 EPS of $0.64, $0.05 worse than the analyst estimate of $0.69. Revenue for the quarter came in at $278 million versus the consensus estimate of $266.55 million.

GUIDANCE:

Ingevity sees FY2026 EPS of $4.80-$5.20, versus the consensus of $4.47. Ingevity sees FY2026 revenue of $1.1-1.2 billion, versus the consensus of $1.18 billion.

For earnings history and earnings-related data on Ingevity (NGVT) click here.